<?xml version="1.0" encoding="UTF-8"?>
<p id="p0050">Similar trends of comorbidities were observed in an analysis of 355 patients who died of COVID-19 in Italy, with pre-existing HTN, DM, CAD, atrial fibrillation, and cerebrovascular disease recorded in 76%, 35.5%, 30%, 24.5%, and 9.6%, respectively.
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref> Finally, preliminary data from the United States involving 7162 patients with COVID-19 revealed the presence of DM in 10.9% and prior CVD in 9% of patients.
 <xref rid="bib17" ref-type="bibr">
  <sup>17</sup>
 </xref> It was also revealed that the presence of underlying health conditions such as DM, chronic lung disease, and CVD, were associated with a higher risk of developing severe COVID-19â€“associated disease than persons without these conditions.
 <xref rid="bib17" ref-type="bibr">
  <sup>17</sup>
 </xref>
</p>
